This product has developed a new therapeutic strategy targeting the α-hemolysin of Staphylococcus aureus, utilizing HEK293F cells to express an IgG-like scFv-Fc for enhanced stability and functionality. Functional validation shows that this antibody can effectively protect cells and has the ability to neutralize α-hemolysin, indicating its potential in combating bacterial toxins. The research findings provide a novel preventive method against MRSA infections, establishing both a theoretical foundation and experimental evidence. The development of this antibody offers new ideas and directions for the treatment of MRSA-related infections, aiming to alleviate the treatment challenges posed by such infections. Overall, this innovative antibody has broad application prospects in improving infection control strategies.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-301-MZ | Mouse Anti-HLY Recombinant Antibody (clone 3) | ELISA, WB | Mouse IgG1 |
There are currently no Customer reviews or questions for VS-0125-FY97. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.